Figures & data
Table 1 Prevalence rates (per 1,000 persons) and incidence rates (per 1,000 person-years) by GOLD category
Figure 1 Age-stratified prevalence rates by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) category.
![Figure 1 Age-stratified prevalence rates by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) category.](/cms/asset/983071b2-c319-4d99-9ff8-bf667e394fd7/dcop_a_82064_f0001_c.jpg)
Figure 2 Age-stratified incidence rates by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) category.
![Figure 2 Age-stratified incidence rates by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) category.](/cms/asset/f0ab5b28-cab9-49f5-9b22-e61506391443/dcop_a_82064_f0002_c.jpg)
Table 2 Characteristics of the prevalent and incident cohorts
Table 3 COPD therapy for stable COPD in the prevalent and incident cohorts
Table 4 GOLD classification parameters for the prevalent and incident cohorts
Table 5 Characteristics of the prevalent cohort: GOLD A/B and GOLD C/D
Table 6 COPD therapy for stable COPD in the prevalent cohort: GOLD A/B and GOLD C/D
Table 7 Characteristics of the incident cohort: GOLD A/B and GOLD C/D
Table 8 Chronic obstructive pulmonary disease maintenance therapy in the incident cohort: GOLD A/B and GOLD C/D